Cerity Partners’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$389K Sell
2,851
-59
-2% -$7.25K ﹤0.01% 2601
2026
Q1
$343K Buy
2,910
+192
+7% +$26.8K ﹤0.01% 2514
2025
Q4
$445K Buy
2,718
+157
+6% +$24.6K ﹤0.01% 2181
2025
Q3
$342K Buy
+2,561
New +$311K ﹤0.01% 2198
2025
Q2
Sell
-2,736
Closed -$348K 2737
2025
Q1
$348K Sell
2,736
-1,461
-35% -$225K ﹤0.01% 1947
2024
Q4
$613K Sell
4,197
-1,344
-24% -$193K ﹤0.01% 1644
2024
Q3
$825K Buy
5,541
+2,625
+90% +$376K ﹤0.01% 1498
2024
Q2
$368K Sell
2,916
-1,143
-28% -$179K ﹤0.01% 1704
2024
Q1
$746K Buy
4,059
+1,391
+52% +$265K ﹤0.01% 1412
2023
Q4
$480K Buy
2,668
+1,090
+69% +$170K ﹤0.01% 1288
2023
Q3
$251K Sell
1,578
-719
-31% -$118K ﹤0.01% 1206
2023
Q2
$325K Sell
2,297
-5,632
-71% -$903K ﹤0.01% 1361
2023
Q1
$1.33M Buy
7,929
+6,100
+334% +$1.09M ﹤0.01% 858
2022
Q4
$310K Buy
1,829
+109
+6% +$19.8K ﹤0.01% 1136
2022
Q3
$322K Buy
1,720
+84
+5% +$17.7K ﹤0.01% 860
2022
Q2
$266K Buy
1,636
+39
+2% +$6.17K ﹤0.01% 954
2022
Q1
$301K Buy
1,597
+405
+34% +$76.9K ﹤0.01% 725
2021
Q4
$316K Buy
+1,192
New +$321K ﹤0.01% 748

Other funds holding RGEN

Cerity Partners's RGEN Position: Q2 2026 in Review

Cerity Partners reduced its Repligen (RGEN) stake by 2% in Q2 2026, selling an estimated $7.25K and leaving 2,851 shares worth $389K. The position accounts for ﹤0.01% of the portfolio, ranked #2601.

Cerity Partners first reported a position in RGEN in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.33M in Q1 2023. 444 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Cerity Partners held 2,851 shares of Repligen worth $389K as of Q2 2026.
  • Cerity Partners sold 59 Repligen shares in Q2 2026, an estimated $7.25K.
  • Repligen made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #2601 holding.
  • Cerity Partners first reported a position in Repligen in Q4 2021 and has held it in 18 quarters since.
  • Cerity Partners's Repligen position peaked at $1.33M in Q1 2023.
  • 444 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.